New eczema ointment shows promise in early trial
NCT ID NCT07158151
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested an ointment called RSS0393 in 168 adults with mild to moderate atopic dermatitis (eczema). Participants used different strengths of the ointment or a placebo for a set period. The goal was to see if the ointment could clear or nearly clear the skin rash. Results will help decide if larger studies are needed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- RSS0393 ointment
- What this could lead to
- If successful, this could provide a new topical treatment option for adults with mild to moderate atopic dermatitis.
- What could go wrong
- This is a Phase 2 trial with only 168 participants, so results may not confirm effectiveness or safety. The ointment may not work better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS OF ADULTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, 510091, China